Evidence map›Paper›PMID 38656138›Full record

ArticleAntimicrobial agents and chemotherapy2024

Barbara A Brown-Elliott, Georgie Bush, M Dolores Hughes, Eliana Rodriguez, Chase A Weikel, Sharon B Min, Richard J Wallace

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Pulmonary infection by non-tuberculous mycobacteria in an endemic region for tuberculosis in Northeast Brazil.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Barbara A Brown-ElliottThe University of Texas Health Science Center at Tyler, Mycobacteria/Nocardia Laboratory, The University of Texas at Tyler School of Medicine, Tyler, Texas, USA.ORCID 0000-0002-3091-1169
Georgie BushThe University of Texas Health Science Center at Tyler, Mycobacteria/Nocardia Laboratory, The University of Texas at Tyler School of Medicine, Tyler, Texas, USA.
M Dolores HughesThe University of Texas Health Science Center at Tyler, Mycobacteria/Nocardia Laboratory, The University of Texas at Tyler School of Medicine, Tyler, Texas, USA.
Eliana RodriguezThe University of Texas Health Science Center at Tyler, Mycobacteria/Nocardia Laboratory, The University of Texas at Tyler School of Medicine, Tyler, Texas, USA.
Chase A WeikelDepartment of Infectious Diseases, GSK, Collegeville, Pennsylvania, USA.
Sharon B MinDepartment of Infectious Diseases, GSK, Collegeville, Pennsylvania, USA.
Richard J WallaceThe University of Texas Health Science Center at Tyler, Mycobacteria/Nocardia Laboratory, The University of Texas at Tyler School of Medicine, Tyler, Texas, USA.
The University of Texas at Tyler · USGlaxoSmithKline (United States) · US

Funding

GSK RDP-CW591261
6 · The paper itself

Abstract

Novel antimicrobials are needed to treat rising nontuberculous mycobacteria (NTM) infections. Using standard broth microdilution methods, 68 NTM isolates were tested against gepotidacin, a new, first-in-class, oral triazaacenaphthylene bacterial topoisomerase inhibitor. MICs varied (0.25 to >64 µg/mL) with the lowest being

Indexed as

AcenaphthenesAnti-Bacterial AgentsMicrobial Sensitivity TestsMycobacterium Infections, NontuberculousNontuberculous MycobacteriaHeterocyclic Compounds, 3-RingHumansAcenaphthenesAnti-Bacterial AgentsgepotidacinHeterocyclic Compounds, 3-Ringantimicrobial activitygepotidacinnontuberculous mycobacteriarapidly growing mycobacteriaslowly growing mycobacteria

Identifiers

PMID38656138
PMCPMC11620510
OpenAlexW4395112404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.